Technical Analysis for ELDN - Eledon Pharmaceuticals, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bullish Signal Line Cross | Bullish | 14.17% | |
| New 52 Week Closing High | Bullish | 14.17% | |
| New 52 Week High | Strength | 14.17% | |
| Wide Bands | Range Expansion | 14.17% | |
| 20 DMA Support | Bullish | 22.22% | |
| Wide Bands | Range Expansion | 22.22% | |
| MACD Bearish Signal Line Cross | Bearish | 30.59% | |
| 20 DMA Support | Bullish | 30.59% | |
| Wide Bands | Range Expansion | 30.59% | |
| Down 3 Days in a Row | Weakness | 30.59% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 5 hours ago |
| New 52 Week High | about 5 hours ago |
| Rose Above Upper Bollinger Band | about 5 hours ago |
| 2x Volume Pace | about 5 hours ago |
| 1.5x Volume Pace | about 5 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Eledon Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing products for patients with disorders of ear, nose, and throat. The company's lead product is OP0201, a surfactant-based nasal aerosol drug-device combination product for patients at risk for, or with, otitis media (OM) (middle ear inflammation with or without infection). It also has a foam-based drug delivery technology OP0101 and OP0102 that could be used to deliver drugs into the ear, nose, and sinus cavities. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Health Sciences Medication Infection Disorders Sinus Audiology Pediatrics Otorhinolaryngology Pernix Therapeutics Holdings
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Health Sciences Medication Infection Disorders Sinus Audiology Pediatrics Otorhinolaryngology Pernix Therapeutics Holdings
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2.54 |
| 52 Week Low | 1.07 |
| Average Volume | 182,373 |
| 200-Day Moving Average | 1.60 |
| 50-Day Moving Average | 1.95 |
| 20-Day Moving Average | 2.24 |
| 10-Day Moving Average | 2.36 |
| Average True Range | 0.22 |
| RSI (14) | 61.98 |
| ADX | 19.13 |
| +DI | 25.24 |
| -DI | 19.95 |
| Chandelier Exit (Long, 3 ATRs) | 1.87 |
| Chandelier Exit (Short, 3 ATRs) | 2.22 |
| Upper Bollinger Bands | 2.61 |
| Lower Bollinger Band | 1.87 |
| Percent B (%b) | 0.86 |
| BandWidth | 33.05 |
| MACD Line | 0.14 |
| MACD Signal Line | 0.14 |
| MACD Histogram | 0.0021 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.81 | ||||
| Resistance 3 (R3) | 2.78 | 2.66 | 2.76 | ||
| Resistance 2 (R2) | 2.66 | 2.59 | 2.67 | 2.74 | |
| Resistance 1 (R1) | 2.58 | 2.54 | 2.62 | 2.61 | 2.72 |
| Pivot Point | 2.46 | 2.46 | 2.48 | 2.47 | 2.46 |
| Support 1 (S1) | 2.38 | 2.39 | 2.42 | 2.41 | 2.29 |
| Support 2 (S2) | 2.26 | 2.34 | 2.27 | 2.27 | |
| Support 3 (S3) | 2.18 | 2.26 | 2.26 | ||
| Support 4 (S4) | 2.21 |
